Enhancing Radiotherapeutic Effect With Nanoparticle-Mediated Radiosensitizer Delivery Guided By Focused Gamma Rays In Lewis Lung Carcinoma-Bearing Mouse Brain Tumor Models

References

• Nabors LB, Ammirati M, Bierman PJ, et al. Central nervous system cancers. J Natl Compr Canc Netw. 2013;11(9):1114–1151. doi:10.6004/jnccn.2013.013224029126
   PubMedGoogle Scholar
• Hua L, Wang Z, Zhao L, et al. Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo- and radiotherapy. Theranostics. 2018;8(18):5088–5105. doi:10.7150/thno.26225.eCollection201830429888
   PubMedGoogle Scholar
• Skiba-Tatarska M, Kusa-Podkanska M, Surtel A, Wysokinska-Miszczuk J. The side-effects of head and neck tumors radiotherapy. Polski Merkuriusz Lekarski. 2016;41(241):47–49. PMID: 2773482227734822
   PubMedGoogle Scholar
• Tabrizi S, Yeap BY, Sherman JC, et al. Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma. Radiother Oncol. 2019;137:95–101. doi:10.1016/j.radonc.2019.04.02731082632
   PubMed Web of Science ®Google Scholar
• Taylor CW, Kirby AM. Cardiac side-effects from breast cancer radiotherapy. Clin Oncol. 2015;27(11):621–629. doi:10.1016/j.clon.2015.06.007
   Web of Science ®Google Scholar
• Ohta K, Murata H, Mori Y, et al. Remodeling of the tumor microenvironment by combined treatment with a novel radiosensitizer, {alpha}-sulfoquinovosylmonoacylglycerol ({alpha}-SQMG) and X-irradiation. Anticancer Res. 2010;30(11):4397–404. PMID: 21115885 21115885
   PubMed Web of Science ®Google Scholar
• Yagisawa T, Okumi M, Omoto K, Sawada Y, Morikawa S, Tanabe K. Novel approach for bladder cancer treatment using sulfoquinovosylacylpropanediol as a radiosensitizer. Int J Urol. 2016;23(3):270–272. doi:10.1111/iju.2016.23.issue-326690732
   PubMedGoogle Scholar
• Yue WY, Clark JJ, Telisak M, Hansen MR. Inhibition of c-Jun N-terminal kinase activity enhances vestibular schwannoma cell sensitivity to gamma irradiation. Neurosurgery. 2013;73(3):506–516. doi:10.1227/01.neu.0000431483.10031.8923728448
   PubMedGoogle Scholar
• Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell. 2000;103(2):239–252. doi:10.1016/S0092-8674(00)00116-111057897
   PubMed Web of Science ®Google Scholar
• Bode AM, Dong Z. The functional contrariety of JNK. Mol Carcinog. 2007;46(8):591–598. doi:10.1002/(ISSN)1098-274417538955
   PubMedGoogle Scholar
• Lu C, Zhu F, Cho YY, et al. Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3. Mol Cell. 2006;23(1):121–132. doi:10.1016/j.molcel.2006.05.02316818236
   PubMedGoogle Scholar
• Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Genet Dev. 2002;12(1):14–21. doi:10.1016/S0959-437X(01)00258-111790549
   PubMed Web of Science ®Google Scholar
• Bulgin D, Podtcheko A, Takakura S, et al. Selective pharmacologic inhibition of c-Jun NH2-terminal kinase radiosensitizes thyroid anaplastic cancer cell lines via induction of terminal growth arrest. Thyroid. 2006;16(3):217–224. doi:10.1089/thy.2006.16.21716571083
   PubMedGoogle Scholar
• Kang YH, Lee SJ. Role of p38 MAPK and JNK in enhanced cervical cancer cell killing by the combination of arsenic trioxide and ionizing radiation. Oncol Rep. 2008;20(3):637–643. doi:10.3892/or_0000005318695917
   PubMedGoogle Scholar
• Kook SH, Son YO, Jang YS, et al. Inhibition of c-Jun N-terminal kinase sensitizes tumor cells to flavonoid-induced apoptosis through down-regulation of JunD. Toxicol Appl Pharmacol. 2008;227(3):468–476. doi:10.1016/j.taap.2007.11.00418078968
   PubMed Web of Science ®Google Scholar
• An J, Chervin AS, Nie A, Ducoff HS, Huang Z. Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor. Oncogene. 2007;26(5):652–661. doi:10.1038/sj.onc.120983016909121
   PubMedGoogle Scholar
• Li CH, Lim SH, Ryu HH, Moon KS, Jung TY, Jung S. Enhancement of radiosensitivity by inhibition of c-Jun N-terminal kinase activity in a Lewis lung carcinomabearing subcutaneous tumor mouse model. Oncol Rep. 2016;36(6):3397–3404. doi:10.3892/or.2016.520427779695
   PubMedGoogle Scholar
• Rizvi SAA, Saleh AM. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J. 2018;26(1):64–70. doi:10.1016/j.jsps.2017.10.01229379334
   PubMed Web of Science ®Google Scholar
• Tiwari G, Tiwari R, Sriwastawa B, et al. Drug delivery systems: an updated review. Int J Pharm Investig. 2012;2(1):2–11. doi:10.4103/2230-973X.96920
   PubMedGoogle Scholar
• Han L, Kong DK, Zheng MQ, et al. Increased nanoparticle delivery to brain tumors by autocatalytic priming for improved treatment and imaging. ACS Nano. 2016;10(4):4209–4218. doi:10.1021/acsnano.5b0757326967254
   PubMed Web of Science ®Google Scholar
• Jain KK. A critical overview of targeted therapies for glioblastoma. Front Oncol. 2018;8:419. doi:10.3389/fonc.2018.0041930374421
   PubMed Web of Science ®Google Scholar
• Saraiva C, Praca C, Ferreira R, Santos T, Ferreira L, Bernardino L. Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release. 2016;235:34–47. doi:10.1016/j.jconrel.2016.05.04427208862
   PubMed Web of Science ®Google Scholar
• Zong Z, Hua L, Wang Z, et al. Self-assembled angiopep-2 modified lipid-poly (hypoxic radiosensitized polyprodrug) nanoparticles delivery TMZ for glioma synergistic TMZ and RT therapy. Drug Deliv. 2019;26(1):34–44. doi:10.1080/10717544.2018.153489730744436
   PubMed Web of Science ®Google Scholar
• Hariri G, Yan H, Wang H, Han Z, Hallahan DE. Radiation-guided drug delivery to mouse models of lung cancer. Clin Cancer Res. 2010;16(20):4968–4977. doi:10.1158/1078-0432.CCR-10-096920802016
   PubMedGoogle Scholar
• Hallahan DE, Qu S, Geng L, et al. Radiation-mediated control of drug delivery. Am J Clin Oncol. 2001;24(5):473–480. doi:10.1097/00000421-200110000-0001211586099
   PubMedGoogle Scholar
• Passarella RJ, Spratt DE, van der Ende AE, et al. Targeted nanoparticles that deliver a sustained, specific release of Paclitaxel to irradiated tumors. Cancer Res. 2010;70(11):4550–4559. doi:10.1158/0008-5472.CAN-10-033920484031
   PubMedGoogle Scholar
• Han M, Wang H, Zhang HT, Han Z. The PDZ protein TIP-1 facilitates cell migration and pulmonary metastasis of human invasive breast cancer cells in athymic mice. Biochem Biophys Res Commun. 2012;422(1):139–145. doi:10.1016/j.bbrc.2012.04.12322564736
   PubMedGoogle Scholar
• Han M, Wang H, Zhang HT, Han Z. Expression of TIP-1 confers radioresistance of malignant glioma cells. PLoS One. 2012;7(9):e45402. doi:10.1371/journal.pone.004540223028987
   PubMedGoogle Scholar
• Wang H, Yan H, Fu A, Han M, Hallahan D, Han Z. TIP-1 translocation onto the cell plasma membrane is a molecular biomarker of tumor response to ionizing radiation. PLoS One. 2010;5(8):e12051. doi:10.1371/journal.pone.001205120711449
   PubMedGoogle Scholar
• Derfus AM, von Maltzahn G, Harris TJ, et al. Remotely triggered release from magnetic nanoparticles. Adv Mater. 2007;19(22):3932. doi:10.1002/(ISSN)1521-4095
   Web of Science ®Google Scholar
• Peppicelli S, Andreucci E, Ruzzolini J, et al. The acidic microenvironment as a possible niche of dormant tumor cells. Cel Mol Life Sci. 2017;74(15):2761–2771. doi:10.1007/s00018-017-2496-y
   PubMed Web of Science ®Google Scholar
• Lim SH, Jung S. inventors; Chonnam National University Hospital, assignee. Irradiation Device for Stereotactic Irradiation of Gamma-Rays and Experimental Method Thereof. Republic of korea Patent 1018223980000 2018 Jan 22doi:10.8080/1020170016855.
   Google Scholar
• Lim SH, Jung TY, Jung S, et al. Quantitative feasibility evaluation of 11C-Methionine positron emission tomography images in gamma knife radiosurgery : phantom-based study and clinical application. J Korean Neurosurg Soc. 2019;62:476–486. doi:10.3340/jkns.2019.010431154754
   PubMedGoogle Scholar
• Li S, Li C, Ryu HH, Lim SH, Jang WY, Jung S. Bacitracin inhibits the migration of U87-MG glioma cells via interferences of the integrin outside-in signaling pathway. J Korean Neurosurg Soc. 2016;59(2):106–116. doi:10.3340/jkns.2016.59.2.10626962415
   PubMed Web of Science ®Google Scholar
• Jin SG, Ryu HH, Li SY, et al. Nogo-A inhibits the migration and invasion of human malignant glioma U87MG cells. Oncol Rep. 2016;35(6):3395–3402. doi:10.3892/or.2016.473727109183
   PubMed Web of Science ®Google Scholar
• Kim TW, Ryu HH, Li SY, et al. PDIA6 regulation of ADAM17 shedding activity and EGFR-mediated migration and invasion of glioblastoma cells. J Neurosurg. 2017;126(6):1829–1838. doi:10.3171/2016.5.JNS15283127540907
   PubMedGoogle Scholar
• Pei J, Park IH, Ryu HH, et al. Sublethal dose of irradiation enhances invasion of malignant glioma cells through p53-MMP 2 pathway in U87MG mouse brain tumor model. Radiat Oncol. 2015;10:164. doi:10.1186/s13014-015-0475-826245666
   PubMedGoogle Scholar
• Han MS, Jang WY, Moon KS, et al. Is fractionated gamma knife radiosurgery a safe and effective treatment approach for large-volume (>10 cm(3)) intracranial meningiomas? World Neurosurg. 2017;99:477–483. doi:10.1016/j.wneu.2016.12.05628017757
   PubMedGoogle Scholar
• Hall EJ. Radiobiology for the Radiologist. 5th ed. Lippincott Williams & Wilkins; 2000.
   Google Scholar
• Tai W, Mahato R, Cheng K. The role of HER2 in cancer therapy and targeted drug delivery. J Control Release. 2010;146(3):264–275. doi:10.1016/j.jconrel.2010.04.00920385184
   PubMed Web of Science ®Google Scholar
• Wu AM, Senter PD. Arming antibodies: prospects and challenges for immunoconjugates. Nat Biotechnol. 2005;23(9):1137–1146. doi:10.1038/nbt114116151407
   PubMed Web of Science ®Google Scholar
• Lin PC, He JY, Le YY, et al. Radiation-guided peptide delivery in a mouse model of nasopharyngeal carcinoma. Biomed Res Int. 2016;2016:5382047. doi:10.1155/2016/538204727738632
   PubMedGoogle Scholar
• Han SS, Li ZY, Zhu JY, et al. Dual-pH sensitive charge-reversal polypeptide micelles for tumor-triggered targeting uptake and nuclear drug delivery. Small. 2015;11(21):2543–2554. doi:10.1002/smll.20140286525626995
   PubMed Web of Science ®Google Scholar
• Han Z, Fu A, Wang H, et al. Noninvasive assessment of cancer response to therapy. Nat Med. 2008;14(3):343–349. doi:10.1038/nm169118297085
   PubMed Web of Science ®Google Scholar
• Lowery A, Onishko H, Hallahan DE, Han Z. Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors. J Control Release. 2011;150(1):117–124. doi:10.1016/j.jconrel.2010.11.00621075152
   PubMedGoogle Scholar
• Pridgen EM, Langer R, Farokhzad OC. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Nanomedicine. 2007;2(5):669–680. doi:10.2217/17435889.2.5.66917976029
   PubMed Web of Science ®Google Scholar
• Ashfaq UA, Riaz M, Yasmeen E, Yousaf MZ. Recent advances in nanoparticle-based targeted drug-delivery systems against cancer and role of tumor microenvironment. Crit Rev Ther Drug Carrier Syst. 2017;34(4):317–353. doi:10.1615/CritRevTherDrugCarrierSyst.v34.i429199588
   PubMed Web of Science ®Google Scholar
• Kim HJ, Kim A, Miyata K, Kataoka K. Recent progress in development of siRNA delivery vehicles for cancer therapy. Adv Drug Deliv Rev. 2016;104:61–77. doi:10.1016/j.addr.2016.06.01127352638
   PubMed Web of Science ®Google Scholar
• Wickens JM, Alsaab HO, Kesharwani P, et al. Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy. Drug Discov Today. 2017;22(4):665–680. doi:10.1016/j.drudis.2016.12.00928017836
   PubMed Web of Science ®Google Scholar
• Qiao J, Dong P, Mu X, Qi L, Xiao R. Folic acid-conjugated fluorescent polymer for up-regulation folate receptor expression study via targeted imaging of tumor cells. Biosens Bioelectron. 2016;78:147–153. doi:10.1016/j.bios.2015.11.02126606305
   PubMedGoogle Scholar
• Danhier F, Feron O, Preat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 2010;148(2):135–146. doi:10.1016/j.jconrel.2010.08.02720797419
   PubMed Web of Science ®Google Scholar
• Chaurasiya B, Mahanty A, Roy D, Shen Y, Tu J, Sun C. Influence of tumor microenvironment on the distribution and elimination of nano-formulations. Curr Drug Metab. 2016;17(8):783–798. doi:10.2174/138920021766616060709334727280439
   PubMedGoogle Scholar
• Chen D, Zhang G, Li R, et al. Biodegradable, hydrogen peroxide, and glutathione dual responsive nanoparticles for potential programmable paclitaxel release. J Am Chem Soc. 2018;140(24):7373–7376. doi:10.1021/jacs.7b1202529799737
   PubMedGoogle Scholar
• Hayward SL, Wilson CL, Kidambi S. Hyaluronic acid-conjugated liposome nanoparticles for targeted delivery to CD44 overexpressing glioblastoma cells. Oncotarget. 2016;7(23):34158–34171. doi:10.18632/oncotarget.v7i2327120809
   PubMedGoogle Scholar
• Lee HL, Hwang SC, Nah JW, et al. Redox- and pH-responsive nanoparticles release piperlongumine in a stimuli-sensitive manner to inhibit pulmonary metastasis of colorectal carcinoma cells. J Pharm Sci. 2018;107(10):2702–2712. doi:10.1016/j.xphs.2018.06.01129936202
   PubMed Web of Science ®Google Scholar
• Mattheolabakis G, Milane L, Singh A, Amiji MM. Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine. J Drug Target. 2015;23(7–8):605–618. doi:10.3109/1061186X.2015.105207226453158
   PubMed Web of Science ®Google Scholar
• Liu J, Huang Y, Kumar A, et al. pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnol Adv. 2014;32(4):693–710. doi:10.1016/j.biotechadv.2013.11.00924309541
   PubMed Web of Science ®Google Scholar
• Ghassami E, Varshosaz J, Taymouri S. Redox sensitive polysaccharide based nanoparticles for improved cancer treatment: a comprehensive review. Curr Pharm Des. 2018;24(28):3303–3319. doi:10.2174/138161282466618081311484130101696
   PubMedGoogle Scholar
• Zhao J, Yang Y, Han X, et al. Redox-sensitive nanoscale coordination polymers for drug delivery and cancer theranostics. ACS Appl Mater Interfaces. 2017;9(28):23555–23563. doi:10.1021/acsami.7b0753528636308
   PubMed Web of Science ®Google Scholar
• Jeong GW, Jeong YI, Nah JW. Triggered doxorubicin release using redox-sensitive hyaluronic acid-g-stearic acid micelles for targeted cancer therapy. Carbohydr Polym. 2019;209:161–171. doi:10.1016/j.carbpol.2019.01.01830732795
   PubMed Web of Science ®Google Scholar
• Raja MA, Arif M, Feng C, Zeenat S, Liu CG. Synthesis and evaluation of pH-sensitive, self-assembled chitosan-based nanoparticles as efficient doxorubicin carriers. J Biomater Appl. 2017;31(8):1182–1195. doi:10.1177/088532821668118428081668
   PubMedGoogle Scholar
• van Vulpen M, Kal HB, Taphoorn MJ, El-Sharouni SY. Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy? (Review). Oncol Rep. 2002;9(4):683–688. PMID: 1206619212066192
   PubMed Web of Science ®Google Scholar